Akira Pharma Private Limited, a active private limited company, was established on 17 November 2009 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51101DL2009PTC196057. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹7.00 Cr and a paid-up capital of ₹2.41 M.
It upholds a compliant status. Its leadership includes Gurpreet Sandhu Singh (Director), Trilochan Singh Sandhu (Director). Past directors included Harshit Singh, Anuradha Sandhu. It holds ₹3.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-4 , Ground Floor , Part A, Village Mahipalpur, Main Vasant Kunj Road, Opp. Jagan Nath Complex, New Delhi, Delhi, 110037.
U51101DL2009PTC196057
196057
17 November 2009
₹7.00 Cr
₹2.41 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Akira Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gurpreet Sandhu Singh | Director | 17 Nov 2009 | Current |
| Trilochan Singh Sandhu | Director | 19 Aug 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Company Secretary | 30 Nov 2019 | Past |
| Pramod Abcsdd | Director | 20 Aug 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Akira Pharma Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 7.73% decrease. The company also saw a substantial improvement in profitability, with a 95.69% increase in profit. The company's net worth dipped by a decrease of 0.14%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Akira Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹29,977,300.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Oct 2024 | Hdfc Bank Limited | ₹1.60 Cr | Open |
| 23 Mar 2024 | Others | ₹1.40 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Akira Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Akira Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akira Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 1.60 Cr with Charge ID 101022084 was registered on 14 Oct 2024. was documented.
Progress on Akira Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Akira Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 1.40 Cr with Charge ID 100958317 was registered on 23 Mar 2024. was completed.
Trilochan Singh Sandhu was appointed as a Director was appointed as a Director on 19 Aug 2013 & has been associated with this company since 12 years 4 months . was recorded as a recent event.
Gurpreet Sandhu Singh was appointed as a Director was appointed as a Director on 17 Nov 2009 & has been associated with this company since 16 years 1 month . was recorded as a recent event.
The CIN of Akira Pharma Private Limited is U51101DL2009PTC196057.
Akira Pharma Private Limited is headquartered at A-4 , Ground Floor , Part A, Village Mahipalpur, Main Vasant Kunj Road, Opp. Jagan Nath Complex, New Delhi, Delhi, 110037.
Akira Pharma Private Limited was incorporated on 17 November 2009.
The current directors of Akira Pharma Private Limited are
The primary industry of Akira Pharma Private Limited is Trade.
Akira Pharma Private Limited is unlisted.
The authorized capital of Akira Pharma Private Limited is ₹7.00 Cr, and the paid-up capital is ₹2.41 M.
The compliance status of Akira Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX